$150.57
▼ -0.2% Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 2
● 23
▼ 0
Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating
Overview
52-week range
$108
$164
76% of range
Avg surprise (last 3)
+3.7%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
28%
EM ±4.3% · $150 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 27, 2026 | Apr/2026 | $1.49 | $1.40 | +6.4% | +13.7% | +0.7% | earnings |
| Sat Jan 31, 2026 | Jan 2026 | $1.07 | — | — | — | — | financials |
| Wed Aug 27, 2025 | Jul/2025 | $1.37 | $1.36 | +0.7% | — | — | earnings |
| Wed May 28, 2025 | Apr/2025 | $1.31 | $1.26 | +4.0% | — | -0.3% | earnings |
| Fri Jan 31, 2025 | Jan 2025 | $1.11 | — | — | — | — | financials |
| Wed Jul 31, 2024 | Jul 2024 | $0.97 | — | — | — | — | financials |
| Tue Apr 30, 2024 | Apr 2024 | $1.05 | — | — | — | — | financials |
| Wed Jan 31, 2024 | Jan 2024 | $1.18 | — | — | — | — | financials |
| Mon Jul 31, 2023 | Jul 2023 | $0.38 | — | — | — | — | financials |
| Sun Apr 30, 2023 | Apr 2023 | $1.02 | — | — | — | — | financials |
| Tue Jan 31, 2023 | Jan 2023 | $1.19 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $1.80B | — | $1.74B | $1.67B | $1.68B | — | $1.58B |
| Cost of revenue | $845M | $852M | — | $850M | $802M | $782M | — | $723M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $399M | $353M | — | $360M | $300M | $376M | — | $333M |
| Net income | $339M | $305M | — | $336M | $215M | $318M | — | $282M |
| EPS (diluted) | $1.20 | $1.07 | — | $1.18 | $0.75 | $1.11 | — | $0.97 |
Balance sheet (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991M | $997M | $972M | $978M |
| Total current assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B |
| Total assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B |
| Long-term debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | — | $2.14B |
| Total liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B |
| Total equity | $7.12B | $-184M | $6.74B | $6.37B | $-280M | $-381M | $5.90B | $5.90B |